Related Experiment Video
Updated: Jul 20, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Gut microbiota transmission induces cognitive impairment through amyloid pathology in wild-type mice
Chenyi Yang1, Wei Qi1, Wei Li1
1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Abstract:
Alzheimer's disease (AD), the leading cause of dementia, is predominantly sporadic and influenced by non-genetic factors, including the gut microbiota. Cohabitation studies have shown microbial transmission between AD transgenic (Tg) and wild-type (WT) mice, leading to cognitive impairment; however, the mechanisms during early-life co-housing exposure remain largely undetermined. Here, one-month-old WT mice were housed with age-matched AD Tg (5XFAD) mice for 3 months. Gut microbiota composition was profiled by 16S rRNA sequencing, while brain amyloid-β 42 (Aβ42) levels were quantified by enzyme-linked immunosorbent assay (ELISA) and a nanoplasmonic sensor, respectively. Cognitive function was assessed by the Morris water maze and Barnes maze, and a probiotic intervention with Lactobacillus reuteri and Bifidobacterium pseudolongum was tested for therapeutic efficacy. WT mice co-housed with AD Tg mice (defined as ADWT) developed gut dysbiosis with microbial community shifts resembling those of AD Tg mice, accompanied by elevated brain Aβ42 and cognitive impairment. Finally, probiotic treatment reshaped gut microbial profiles and reduced cortical and hippocampal Aβ42 levels in ADWT mice. Together, these findings indicate that microbiota transfer through early-life co-housing induces gut dysbiosis, amyloid pathology, and cognitive deficits in WT mice, while targeted probiotic intervention mitigates these effects, supporting a microbiota-driven, non-genetic pathway in AD pathogenesis.
Insights
Early-life exposure to Alzheimer's disease (AD) mouse microbiota via co-housing induced gut dysbiosis, amyloid pathology, and cognitive deficits in wild-type mice. Probiotic treatment mitigated these AD-like effects.
Area of Science:
- Neuroscience
- Microbiology
- Genetics
Background:
- Alzheimer's disease (AD) is the primary cause of dementia, often sporadic and influenced by non-genetic factors like gut microbiota.
- Early-life microbial transmission between AD transgenic (Tg) and wild-type (WT) mice can cause cognitive issues, but mechanisms are unclear.
Purpose of the Study:
- To investigate the mechanisms of gut microbiota transfer and its impact on cognitive function and amyloid pathology in WT mice exposed to AD Tg mice during early life.
- To evaluate the therapeutic efficacy of a specific probiotic intervention.
Main Methods:
- One-month-old WT mice were co-housed with 5XFAD (AD Tg) mice for three months.
- Gut microbiota composition was analyzed using 16S rRNA sequencing.
- Brain amyloid-β 42 (Aβ42) levels were measured using ELISA and a nanoplasmonic sensor.
- Cognitive function was assessed via Morris water maze and Barnes maze.
- Probiotic treatment (Lactobacillus reuteri and Bifidobacterium pseudolongum) was administered.
Main Results:
- WT mice co-housed with AD Tg mice (ADWT) exhibited gut dysbiosis with microbial profiles similar to AD Tg mice.
- ADWT mice showed elevated brain Aβ42 levels and developed cognitive impairments.
- Probiotic intervention successfully altered gut microbial composition and reduced Aβ42 levels in the cortex and hippocampus of ADWT mice.
Conclusions:
- Microbiota transfer via early-life co-housing induces gut dysbiosis, amyloid pathology, and cognitive deficits in WT mice.
- Targeted probiotic intervention can effectively mitigate these microbiota-driven Alzheimer's disease-like effects.
- These findings support a non-genetic, microbiota-driven pathway in AD pathogenesis.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
Related Concept Videos
Dysbiosis of the Gut Microbiota
Gut-Brain Axis
Amebiasis
Alzheimer Disease ll: Pathophysiology